Showing results (341-350 of 818) with videos related to
Sort By:
Pageof 82
British Journal of Obstetrics and Gynaecology|April 1, 1993
Simulated home delivery in hospital: a randomised controlled trialJ MacVicar, G Dobbie, L Owen-Johnstone, et al.Seminars in Oncology|November 19, 2019
Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitorsAshley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, et al.Anesthesiology|December 10, 2020
Molecular Modification of Transient Receptor Potential Canonical 6 Channels Modulates Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant HyperthermiaJose Rafael Lopez, Arkady Uryash, Jose Adams, et al.European Urology|July 15, 2020
Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with AtezolizumabAshley M Hopkins, Ganessan Kichenadasse, Christos S Karapetis, et al.Journal of Science and Medicine in Sport|December 4, 2018
Thermoregulation and markers of muscle breakdown in malignant hyperthermia susceptible volunteers during an acute heat tolerance testCarol M House, Michael J Tipton, Philip M Hopkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with AtezolizumabAshley M Hopkins, Ganessan Kichenadasse, Christos S Karapetis, et al.Cytometry|September 1, 1988
How reproducible are flow cytometry data from paraffin-embedded blocks?T E Kute, B Gregory, J Galleshaw, et al.International Journal of Oncology|March 12, 2015
Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cellsMandi M Hopkins, Xiaoxing Feng, Mengwei Liu, et al.Journal of Cancer Research and Clinical Oncology|May 26, 2020
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenibWarit Ruanglertboon, Michael J Sorich, Jessica M Logan, et al.American Journal of Physiology. Cell Physiology|March 27, 2004
RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actinMatthias Bruewer, Ann M Hopkins, Michael E Hobert, et al.Pageof 82